世界のウンデシル酸テストステロン（TU）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Testosterone Undecylate (TU) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5609 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ウンデシル酸テストステロン（TU）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、経口）、用途別市場規模（原発性性腺機能低下症、性腺機能低下性性腺機能低下症、遅発性性腺機能低下症）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ウンデシル酸テストステロン（TU）の市場動向 ・企業の競争状況、市場シェア ・ウンデシル酸テストステロン（TU）の種類別市場規模（注射、経口） ・ウンデシル酸テストステロン（TU）の用途別市場規模（原発性性腺機能低下症、性腺機能低下性性腺機能低下症、遅発性性腺機能低下症） ・ウンデシル酸テストステロン（TU）の北米市場規模2016-2027（アメリカ、カナダ） ・ウンデシル酸テストステロン（TU）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ウンデシル酸テストステロン（TU）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ウンデシル酸テストステロン（TU）の中南米市場規模2016-2027（メキシコ、ブラジル） ・ウンデシル酸テストステロン（TU）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Organon、Bayer AG、Endo Pharmaceuticals、Merck Sharp & Dohme、Taro Pharmaceutical、Cipla、Clarus Therapeutics、Zhejiang Xianju Pharmaceutical、Zhejiang Medicine） ・結論

Testosterone undecanoate is the ester prodrug of testosterone and has a midchain fatty acid at the 17Beta position.It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency.

Market Analysis and Insights: Global Testosterone Undecylate (TU) Market
The global Testosterone Undecylate (TU) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Testosterone Undecylate (TU) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Testosterone Undecylate (TU) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Testosterone Undecylate (TU) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Testosterone Undecylate (TU) market.

Global Testosterone Undecylate (TU) Scope and Market Size
Testosterone Undecylate (TU) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Testosterone Undecylate (TU) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Injection
Oral

Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Organon
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Clarus Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Testosterone Undecylate (TU) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Testosterone Undecylate (TU) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Testosterone Undecylate (TU) Market Perspective (2016-2027)
2.2 Testosterone Undecylate (TU) Growth Trends by Regions
2.2.1 Testosterone Undecylate (TU) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Testosterone Undecylate (TU) Historic Market Share by Regions (2016-2021)
2.2.3 Testosterone Undecylate (TU) Forecasted Market Size by Regions (2022-2027)
2.3 Testosterone Undecylate (TU) Industry Dynamic
2.3.1 Testosterone Undecylate (TU) Market Trends
2.3.2 Testosterone Undecylate (TU) Market Drivers
2.3.3 Testosterone Undecylate (TU) Market Challenges
2.3.4 Testosterone Undecylate (TU) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Testosterone Undecylate (TU) Players by Revenue
3.1.1 Global Top Testosterone Undecylate (TU) Players by Revenue (2016-2021)
3.1.2 Global Testosterone Undecylate (TU) Revenue Market Share by Players (2016-2021)
3.2 Global Testosterone Undecylate (TU) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Testosterone Undecylate (TU) Revenue
3.4 Global Testosterone Undecylate (TU) Market Concentration Ratio
3.4.1 Global Testosterone Undecylate (TU) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Testosterone Undecylate (TU) Revenue in 2020
3.5 Testosterone Undecylate (TU) Key Players Head office and Area Served
3.6 Key Players Testosterone Undecylate (TU) Product Solution and Service
3.7 Date of Enter into Testosterone Undecylate (TU) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Testosterone Undecylate (TU) Breakdown Data by Type
4.1 Global Testosterone Undecylate (TU) Historic Market Size by Type (2016-2021)
4.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Type (2022-2027)

5 Testosterone Undecylate (TU) Breakdown Data by Application
5.1 Global Testosterone Undecylate (TU) Historic Market Size by Application (2016-2021)
5.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Testosterone Undecylate (TU) Market Size (2016-2027)
6.2 North America Testosterone Undecylate (TU) Market Size by Type
6.2.1 North America Testosterone Undecylate (TU) Market Size by Type (2016-2021)
6.2.2 North America Testosterone Undecylate (TU) Market Size by Type (2022-2027)
6.2.3 North America Testosterone Undecylate (TU) Market Size by Type (2016-2027)
6.3 North America Testosterone Undecylate (TU) Market Size by Application
6.3.1 North America Testosterone Undecylate (TU) Market Size by Application (2016-2021)
6.3.2 North America Testosterone Undecylate (TU) Market Size by Application (2022-2027)
6.3.3 North America Testosterone Undecylate (TU) Market Size by Application (2016-2027)
6.4 North America Testosterone Undecylate (TU) Market Size by Country
6.4.1 North America Testosterone Undecylate (TU) Market Size by Country (2016-2021)
6.4.2 North America Testosterone Undecylate (TU) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Testosterone Undecylate (TU) Market Size (2016-2027)
7.2 Europe Testosterone Undecylate (TU) Market Size by Type
7.2.1 Europe Testosterone Undecylate (TU) Market Size by Type (2016-2021)
7.2.2 Europe Testosterone Undecylate (TU) Market Size by Type (2022-2027)
7.2.3 Europe Testosterone Undecylate (TU) Market Size by Type (2016-2027)
7.3 Europe Testosterone Undecylate (TU) Market Size by Application
7.3.1 Europe Testosterone Undecylate (TU) Market Size by Application (2016-2021)
7.3.2 Europe Testosterone Undecylate (TU) Market Size by Application (2022-2027)
7.3.3 Europe Testosterone Undecylate (TU) Market Size by Application (2016-2027)
7.4 Europe Testosterone Undecylate (TU) Market Size by Country
7.4.1 Europe Testosterone Undecylate (TU) Market Size by Country (2016-2021)
7.4.2 Europe Testosterone Undecylate (TU) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Testosterone Undecylate (TU) Market Size (2016-2027)
8.2 Asia-Pacific Testosterone Undecylate (TU) Market Size by Type
8.2.1 Asia-Pacific Testosterone Undecylate (TU) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Testosterone Undecylate (TU) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Testosterone Undecylate (TU) Market Size by Type (2016-2027)
8.3 Asia-Pacific Testosterone Undecylate (TU) Market Size by Application
8.3.1 Asia-Pacific Testosterone Undecylate (TU) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Testosterone Undecylate (TU) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Testosterone Undecylate (TU) Market Size by Application (2016-2027)
8.4 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region
8.4.1 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Testosterone Undecylate (TU) Market Size (2016-2027)
9.2 Latin America Testosterone Undecylate (TU) Market Size by Type
9.2.1 Latin America Testosterone Undecylate (TU) Market Size by Type (2016-2021)
9.2.2 Latin America Testosterone Undecylate (TU) Market Size by Type (2022-2027)
9.2.3 Latin America Testosterone Undecylate (TU) Market Size by Type (2016-2027)
9.3 Latin America Testosterone Undecylate (TU) Market Size by Application
9.3.1 Latin America Testosterone Undecylate (TU) Market Size by Application (2016-2021)
9.3.2 Latin America Testosterone Undecylate (TU) Market Size by Application (2022-2027)
9.3.3 Latin America Testosterone Undecylate (TU) Market Size by Application (2016-2027)
9.4 Latin America Testosterone Undecylate (TU) Market Size by Country
9.4.1 Latin America Testosterone Undecylate (TU) Market Size by Country (2016-2021)
9.4.2 Latin America Testosterone Undecylate (TU) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Testosterone Undecylate (TU) Market Size (2016-2027)
10.2 Middle East & Africa Testosterone Undecylate (TU) Market Size by Type
10.2.1 Middle East & Africa Testosterone Undecylate (TU) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Testosterone Undecylate (TU) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Testosterone Undecylate (TU) Market Size by Type (2016-2027)
10.3 Middle East & Africa Testosterone Undecylate (TU) Market Size by Application
10.3.1 Middle East & Africa Testosterone Undecylate (TU) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Testosterone Undecylate (TU) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Testosterone Undecylate (TU) Market Size by Application (2016-2027)
10.4 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country
10.4.1 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Organon
11.1.1 Organon Company Details
11.1.2 Organon Business Overview
11.1.3 Organon Testosterone Undecylate (TU) Introduction
11.1.4 Organon Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.1.5 Organon Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Testosterone Undecylate (TU) Introduction
11.2.4 Bayer AG Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.2.5 Bayer AG Recent Development
11.3 Endo Pharmaceuticals
11.3.1 Endo Pharmaceuticals Company Details
11.3.2 Endo Pharmaceuticals Business Overview
11.3.3 Endo Pharmaceuticals Testosterone Undecylate (TU) Introduction
11.3.4 Endo Pharmaceuticals Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.3.5 Endo Pharmaceuticals Recent Development
11.4 Merck Sharp & Dohme
11.4.1 Merck Sharp & Dohme Company Details
11.4.2 Merck Sharp & Dohme Business Overview
11.4.3 Merck Sharp & Dohme Testosterone Undecylate (TU) Introduction
11.4.4 Merck Sharp & Dohme Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.4.5 Merck Sharp & Dohme Recent Development
11.5 Taro Pharmaceutical
11.5.1 Taro Pharmaceutical Company Details
11.5.2 Taro Pharmaceutical Business Overview
11.5.3 Taro Pharmaceutical Testosterone Undecylate (TU) Introduction
11.5.4 Taro Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.5.5 Taro Pharmaceutical Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Testosterone Undecylate (TU) Introduction
11.6.4 Cipla Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Clarus Therapeutics
11.7.1 Clarus Therapeutics Company Details
11.7.2 Clarus Therapeutics Business Overview
11.7.3 Clarus Therapeutics Testosterone Undecylate (TU) Introduction
11.7.4 Clarus Therapeutics Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.7.5 Clarus Therapeutics Recent Development
11.8 Zhejiang Xianju Pharmaceutical
11.8.1 Zhejiang Xianju Pharmaceutical Company Details
11.8.2 Zhejiang Xianju Pharmaceutical Business Overview
11.8.3 Zhejiang Xianju Pharmaceutical Testosterone Undecylate (TU) Introduction
11.8.4 Zhejiang Xianju Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.8.5 Zhejiang Xianju Pharmaceutical Recent Development
11.9 Zhejiang Medicine
11.9.1 Zhejiang Medicine Company Details
11.9.2 Zhejiang Medicine Business Overview
11.9.3 Zhejiang Medicine Testosterone Undecylate (TU) Introduction
11.9.4 Zhejiang Medicine Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.9.5 Zhejiang Medicine Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Testosterone Undecylate (TU) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Global Testosterone Undecylate (TU) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Testosterone Undecylate (TU) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Testosterone Undecylate (TU) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Testosterone Undecylate (TU) Market Share by Regions (2016-2021)
Table 8. Global Testosterone Undecylate (TU) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Testosterone Undecylate (TU) Market Share by Regions (2022-2027)
Table 10. Testosterone Undecylate (TU) Market Trends
Table 11. Testosterone Undecylate (TU) Market Drivers
Table 12. Testosterone Undecylate (TU) Market Challenges
Table 13. Testosterone Undecylate (TU) Market Restraints
Table 14. Global Testosterone Undecylate (TU) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Testosterone Undecylate (TU) Market Share by Players (2016-2021)
Table 16. Global Top Testosterone Undecylate (TU) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Testosterone Undecylate (TU) as of 2020)
Table 17. Ranking of Global Top Testosterone Undecylate (TU) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Testosterone Undecylate (TU) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Testosterone Undecylate (TU) Product Solution and Service
Table 21. Date of Enter into Testosterone Undecylate (TU) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Testosterone Undecylate (TU) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Testosterone Undecylate (TU) Revenue Market Share by Type (2016-2021)
Table 25. Global Testosterone Undecylate (TU) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Testosterone Undecylate (TU) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Testosterone Undecylate (TU) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Testosterone Undecylate (TU) Revenue Market Share by Application (2016-2021)
Table 29. Global Testosterone Undecylate (TU) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Testosterone Undecylate (TU) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Testosterone Undecylate (TU) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Testosterone Undecylate (TU) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Testosterone Undecylate (TU) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Testosterone Undecylate (TU) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Testosterone Undecylate (TU) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Testosterone Undecylate (TU) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Testosterone Undecylate (TU) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Testosterone Undecylate (TU) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Testosterone Undecylate (TU) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Testosterone Undecylate (TU) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Testosterone Undecylate (TU) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Testosterone Undecylate (TU) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Testosterone Undecylate (TU) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Testosterone Undecylate (TU) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Testosterone Undecylate (TU) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Testosterone Undecylate (TU) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Testosterone Undecylate (TU) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Testosterone Undecylate (TU) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Testosterone Undecylate (TU) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Testosterone Undecylate (TU) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Testosterone Undecylate (TU) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Testosterone Undecylate (TU) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Testosterone Undecylate (TU) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Testosterone Undecylate (TU) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Testosterone Undecylate (TU) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Testosterone Undecylate (TU) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Organon Company Details
Table 62. Organon Business Overview
Table 63. Organon Testosterone Undecylate (TU) Product
Table 64. Organon Revenue in Testosterone Undecylate (TU) Business (2016-2021) & (US$ Million)
Table 65. Organon Recent Development
Table 66. Bayer AG Company Details
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Testosterone Undecylate (TU) Product
Table 69. Bayer AG Revenue in Testosterone Undecylate (TU) Business (2016-2021) & (US$ Million)
Table 70. Bayer AG Recent Development
Table 71. Endo Pharmaceuticals Company Details
Table 72. Endo Pharmaceuticals Business Overview
Table 73. Endo Pharmaceuticals Testosterone Undecylate (TU) Product
Table 74. Endo Pharmaceuticals Revenue in Testosterone Undecylate (TU) Business (2016-2021) & (US$ Million)
Table 75. Endo Pharmaceuticals Recent Development
Table 76. Merck Sharp & Dohme Company Details
Table 77. Merck Sharp & Dohme Business Overview
Table 78. Merck Sharp & Dohme Testosterone Undecylate (TU) Product
Table 79. Merck Sharp & Dohme Revenue in Testosterone Undecylate (TU) Business (2016-2021) & (US$ Million)
Table 80. Merck Sharp & Dohme Recent Development
Table 81. Taro Pharmaceutical Company Details
Table 82. Taro Pharmaceutical Business Overview
Table 83. Taro Pharmaceutical Testosterone Undecylate (TU) Product
Table 84. Taro Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2016-2021) & (US$ Million)
Table 85. Taro Pharmaceutical Recent Development
Table 86. Cipla Company Details
Table 87. Cipla Business Overview
Table 88. Cipla Testosterone Undecylate (TU) Product
Table 89. Cipla Revenue in Testosterone Undecylate (TU) Business (2016-2021) & (US$ Million)
Table 90. Cipla Recent Development
Table 91. Clarus Therapeutics Company Details
Table 92. Clarus Therapeutics Business Overview
Table 93. Clarus Therapeutics Testosterone Undecylate (TU) Product
Table 94. Clarus Therapeutics Revenue in Testosterone Undecylate (TU) Business (2016-2021) & (US$ Million)
Table 95. Clarus Therapeutics Recent Development
Table 96. Zhejiang Xianju Pharmaceutical Company Details
Table 97. Zhejiang Xianju Pharmaceutical Business Overview
Table 98. Zhejiang Xianju Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2016-2021) & (US$ Million)
Table 99. Zhejiang Xianju Pharmaceutical Recent Development
Table 100. Zhejiang Medicine Company Details
Table 101. Zhejiang Medicine Business Overview
Table 102. Zhejiang Medicine Testosterone Undecylate (TU) Product
Table 103. Zhejiang Medicine Revenue in Testosterone Undecylate (TU) Business (2016-2021) & (US$ Million)
Table 104. Zhejiang Medicine Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Testosterone Undecylate (TU) Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Oral Features
Figure 4. Global Testosterone Undecylate (TU) Market Share by Application: 2020 VS 2027
Figure 5. Primary Hypogonadism Case Studies
Figure 6. Hypogonadotropic Hypogonadism Case Studies
Figure 7. Late-Onset Hypogonadism Case Studies
Figure 8. Testosterone Undecylate (TU) Report Years Considered
Figure 9. Global Testosterone Undecylate (TU) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Testosterone Undecylate (TU) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Testosterone Undecylate (TU) Market Share by Regions: 2020 VS 2027
Figure 12. Global Testosterone Undecylate (TU) Market Share by Regions (2022-2027)
Figure 13. Global Testosterone Undecylate (TU) Market Share by Players in 2020
Figure 14. Global Top Testosterone Undecylate (TU) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Testosterone Undecylate (TU) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Testosterone Undecylate (TU) Revenue in 2020
Figure 16. Global Testosterone Undecylate (TU) Revenue Market Share by Type (2016-2021)
Figure 17. Global Testosterone Undecylate (TU) Revenue Market Share by Type (2022-2027)
Figure 18. North America Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Testosterone Undecylate (TU) Market Share by Type (2016-2027)
Figure 20. North America Testosterone Undecylate (TU) Market Share by Application (2016-2027)
Figure 21. North America Testosterone Undecylate (TU) Market Share by Country (2016-2027)
Figure 22. United States Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Testosterone Undecylate (TU) Market Share by Type (2016-2027)
Figure 26. Europe Testosterone Undecylate (TU) Market Share by Application (2016-2027)
Figure 27. Europe Testosterone Undecylate (TU) Market Share by Country (2016-2027)
Figure 28. Germany Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Testosterone Undecylate (TU) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Testosterone Undecylate (TU) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Testosterone Undecylate (TU) Market Share by Region (2016-2027)
Figure 38. China Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Testosterone Undecylate (TU) Market Share by Type (2016-2027)
Figure 46. Latin America Testosterone Undecylate (TU) Market Share by Application (2016-2027)
Figure 47. Latin America Testosterone Undecylate (TU) Market Share by Country (2016-2027)
Figure 48. Mexico Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Testosterone Undecylate (TU) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Testosterone Undecylate (TU) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Testosterone Undecylate (TU) Market Share by Country (2016-2027)
Figure 54. Turkey Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Testosterone Undecylate (TU) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Organon Revenue Growth Rate in Testosterone Undecylate (TU) Business (2016-2021)
Figure 58. Bayer AG Revenue Growth Rate in Testosterone Undecylate (TU) Business (2016-2021)
Figure 59. Endo Pharmaceuticals Revenue Growth Rate in Testosterone Undecylate (TU) Business (2016-2021)
Figure 60. Merck Sharp & Dohme Revenue Growth Rate in Testosterone Undecylate (TU) Business (2016-2021)
Figure 61. Taro Pharmaceutical Revenue Growth Rate in Testosterone Undecylate (TU) Business (2016-2021)
Figure 62. Cipla Revenue Growth Rate in Testosterone Undecylate (TU) Business (2016-2021)
Figure 63. Clarus Therapeutics Revenue Growth Rate in Testosterone Undecylate (TU) Business (2016-2021)
Figure 64. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Testosterone Undecylate (TU) Business (2016-2021)
Figure 65. Zhejiang Medicine Revenue Growth Rate in Testosterone Undecylate (TU) Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---